The potent combination of CRISPR/Cas9 and zebrafish as a model organism offers enormous potential for research into human diseases caused by point mutations. Three new articles use zebrafish to explore how advances in CRISPR/Cas9 optimization offer a new level of accuracy and specificity previously out of reach for research into this type of human genetic disorder.